Table 2. Antibody levels against Msg, San Francisco General Hospital staff, San Francisco, California, USA, 2007–2009*†.
Antibody | Occupation, estimated geometric mean (95% CI) |
|
p value | |
---|---|---|---|---|
Clinical, n = 396 | Nonclinical, n = 80 | |||
MsgA | 12.0 (11.1–12.9) | 18.4 (17.1–19.9) | 0.45 | |
MsgB | 4.9 (4.6–5.1) | 6.7 (6.3–7.1) | 0.56 | |
MsgC1 | 38.4 (35.9–41.1) | 19.8 (18.6–21.2) | 0.004 | |
MsgC3 | 77.1 (71.9–82.7) | 52.9 (49.4–56.8) | 0.09 | |
MsgC8 | 46.0 (42.9–49.2) | 27.6 (25.8–29.6) | 0.02 | |
MsgC9 | 34.6 (32.7–36.6) | 27.0 (25.5–28.5) | 0.17 |
*Msg, major surface glycoprotein. †By occupation for all time points and for all participants, adjusted for age and immune disorder,